What is Sepragen?
Sepragen operates as a specialized provider of bioprocess chromatography solutions, delivering essential tools for the development and manufacturing of life-saving biological drugs, vaccines, and diagnostics. The company's portfolio encompasses automated chromatography systems, high-performance columns, and specialized resins, complemented by bespoke engineering services. By focusing on the intersection of efficiency and cost-effectiveness, Sepragen serves a diverse clientele spanning the biologics drug manufacturing and health-enhancing human nutrition sectors. Their market position is defined by an ability to streamline complex purification processes, which is a fundamental requirement for companies navigating the transition from laboratory-scale research to commercial-scale production.
How much funding has Sepragen raised?
Sepragen has raised a total of $1.9M across 3 funding rounds:
Debt
$150K
Debt
$1M
Debt
$700K
Debt (2020): $150K with participation from PPP
Debt (2024): $1M, investors not publicly disclosed
Debt (2024): $700K supported by GBC International Bank
Key Investors in Sepragen
GBC International Bank
A financial institution providing specialized commercial banking and debt financing solutions to support industrial growth and capital-intensive projects.
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Sepragen?
With the recent infusion of capital, Sepragen is well-positioned to accelerate its strategic initiatives in the bioprocessing landscape. The company is expected to prioritize the expansion of its automated systems and the refinement of its resin technology to address the increasing complexity of next-generation biologics. As the demand for rapid vaccine development and advanced therapeutic manufacturing continues to rise, Sepragen's focus will likely shift toward enhancing its customized engineering services to provide turnkey solutions for global pharmaceutical partners. This strategic deployment of resources will be vital in maintaining their trajectory as a key enabler of efficient, scalable, and high-quality biological manufacturing processes.
See full Sepragen company page